Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Yurika Kikutani"'
Autor:
Ayako Furugen, Shotaro Sasaki, Natsuko Takahashi, Katsuya Narumi, Toru Konishi, Ken Iseki, Masaki Kobayashi, Yurika Kikutani
Publikováno v:
Journal of pharmaceutical sciences. 105(4)
Statins, 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors, are the most widely used cholesterol-lowering agents for prevention of obstructive cardiovascular events. However, statins can cause a variety of skeletal muscle problems, and exerc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::893eb42da4a8ff62507e4a89400b6a29
https://pubmed.ncbi.nlm.nih.gov/26935883
https://pubmed.ncbi.nlm.nih.gov/26935883
Autor:
Sho Otake, Shotaro Sasaki, Jiro Ogura, Ayako Furugen, Natsuko Takahashi, Katsuya Narumi, Ken Iseki, Hiroaki Yamaguchi, Masaki Kobayashi, Meguho Watanabe, Yurika Kikutani
Publikováno v:
Biologicalpharmaceutical bulletin. 36(9)
Protein kinase C (PKC) modulators are very attractive therapeutic targets in cancer. Since most cancer cells display increased glycolysis, elucidations of the effects of PKC activation on glycolysis is necessary for the development of effective medic
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b9a79afff903c29f6d7cfe8472d3a9e3
https://pubmed.ncbi.nlm.nih.gov/23995654
https://pubmed.ncbi.nlm.nih.gov/23995654
Autor:
Kikutani, Yurika, Kobayashi, Masaki, Konishi, Toru, Sasaki, Shotaro, Narumi, Katsuya, Furugen, Ayako, Takahashi, Natsuko, Iseki, Ken
Publikováno v:
In Journal of Pharmaceutical Sciences April 2016 105(4):1544-1549
Publikováno v:
Drug Metabolism Reviews. Nov2015 Supplement, Vol. 47, p41-297. 257p.